Labverity
Facility profile

Janssen Vaccines, Zweigniederlassung der Cilag GmbH International

Drug product manufacturing · Active pharmaceutical ingredient (API) manufacturing · Berna 3018 · Switzerland

FDA recordFDA directory updated Jul 21, 2026Profile not yet claimed21 registered company locations
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

Active pharmaceutical ingredient (API) manufactureManufacture
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 21, 2026

Latest matched inspection
Voluntary action indicated (VAI)

Dec 7, 2012 · FDA documented observations for voluntary correction.

Matched compliance actions
None in our records

No warning letter, injunction, or seizure matched.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched voluntary action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Ask what was corrected and review any later inspection or follow-up record.

Method and source details
View full inspection and compliance history3 inspection records

FDA inspection history

3 records, Jan 2009 – Dec 2012 · 0 NAI · 3 VAI · 0 OAI

DateClassProject areaCitationsFY
Dec 7, 2012VAIVaccines and Allergenic Products2013
Feb 25, 2011VAIVaccines and Allergenic Products2011
Jan 23, 2009VAIVaccines and Allergenic Products2009

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

No warning letter, injunction, or seizure is matched in the current data set.

Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services